Cardiovascular Week articles from August 2004

Cardiovascular Week archives from August 2004

Methods of measuring cholesterol absorption in humans are clarified.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Study attempts to clarify the benefits of approaches to measure cholesterol absorption in humans. According to recent research from the United States, "Under optimal conditions, plasma cholesterol...

2D cardiothoracic ratio easily extracted from digital PA chest x-rays.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- A two-dimensional (2D) cardiothoracic ratio can be extracted easily using image analysis software, researchers say. According to published research from Canada, "The purpose of our study was to...

CuZn-superoxide dismutase may maintain perfusion in mouse coronary artery.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Researchers report that increasing endogenous levels of CuZn-superoxide dismutase (SOD) in mouse coronary arteries (CA) may maintain coronary perfusion under conditions of hypoxia/reoxygenation (H/R)....

Carvedilol reduces morbidity and mortality of patients in heart failure.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Researchers urge clinical trials of heart failure medications to include the elderly, women and African Americans. "Remarkable improvements in morbidity and mortality caused by heart failure have...

Diet causes blood pressure differences between northern and southern Chinese.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Study shows that several dietary differences are responsible for blood pressure differences between northern and southern Chinese. According to a study from the United States, "Blood pressure and...

Xcelerant for use with Talent AAA Stent Graft System receives CE Mark approval.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Medtronic, Inc., (MDT) announced CE Mark approval and market availability for the Xcelerant Delivery System for use with the Talent Abdominal Aortic Aneurysm (AAA) Stent Graft System. The Talent...

Agreement with FDA reached on clinical development program for diltiazem.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- DOV Pharmaceutical, Inc., (DOVP) has reached agreement with the FDA's (U.S. Food and Drug Administration) Cardio-Renal Division on the scope and design of the clinical trials required for submission of...

Pathway of platelet procoagulant activity is regulated by IQGAP1.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- A shear-restricted pathway of platelet procoagulant activity is regulated by IQGAP1. According to a study from the United States, "Circulating blood platelets regulate the initial phase of the...

Iatrogenic VSD closure with Amplatzer occluder reported.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The Amplatzer occluder can be used to close iatrogenic VSDs in patients who have undergone aortic valve replacement. "Iatrogenic hemodynamically significant ventricular septal defects (VSDs) after...

Effectiveness of ablation for atrial fibrillation has not been established.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Randomized controlled trials are necessary to determine the long-term effectiveness of ablation for atrial fibrillation (AF). "During the past 10 years numerous studies on the treatment of...

Vioxx in high doses causes hypertension.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The evidence is growing: Chronic, high-dose consumption of the arthritis pain reliever Vioxx can raise blood pressure and the risk of serious heart problems. Yet a "substantial number" of patients...

Oxidized lipids, antibodies may be markers for atherogenesis.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The oxidation hypothesis of atherogenesis has been studied and researchers report new evidence that oxidized lipids and antibodies in those lipids may play a role as markers for atherogenesis. "The...

CLAs may modify hepatic gene expression patterns.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Conjugated linoleic acids (CLAs) may have the potential to modify hepatic gene expression patterns, researchers report. "CLAs are isomeric forms of the 18:2 fatty acid that contain conjugated sites...

MDCT and MRI detect atherosclerotic lesions.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Study shows that both multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI) can identify and differentiate atherosclerotic lesions in human ex vivo coronary arteries. ...

Some lipid-lowering drugs can stabilize atherosclerotic plaque.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The fibrinolytic system and lipoproteins are related in the pathogenesis of coronary atherosclerosis. "The fibrinolytic system is comprised of a series of serine proteases and serine protease...

Statins promote collateral neovascularization without causing cancer growth.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Statins promote collateral neovascularization without causing cancer growth. According to a study from Japan, "3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, or statins, are widely...

Irregular heart rhythm linked with sleep disorder.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- People with an irregular heart rhythm are more likely to have sleep apnea than other cardiology patients, according to a new report. Atrial fibrillation (AF) is a heart rhythm abnormality in which...

Medical device manufacturer doubles cholesterol monitor shipments.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Lifestream Technologies (LFTC) announced that shipments in the fourth quarter were twice that of the same quarter ending 2003. The addition of a new retail account contributed to this increase in...

EVLT maker announces sales-organization-expansion milestone.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Diomed Holdings, Inc., (DIO), a developer and marketer of minimally invasive medical technologies, including its patented EndoVenous Laser Treatment (EVLT) of varicose veins, announced the company has...

Company reports rapid adoption of AutoPulse Resuscitation System.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Revivant Corp. announced it has ended the June quarter of 2004 with 25 new customers purchasing AutoPulse Resuscitation Systems during the quarter. The AutoPulse is a noninvasive CPR device that...

Saint-Gobain to install AEDs at work sites.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Saint-Gobain Corporation has purchased automated external defibrillators (AEDs) to treat employees who may suffer from sudden cardiac arrest while on the job, Medtronic has announced. The first...

Disturbed lymphangiogenesis underlies fetal heart malformation.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Disturbed lymphangiogenesis underlies fetal heart malformation. According to recent research published in the journal Developmental Dynamics, "ultrasound measurement of increased nuchal translucency...

Gene therapy shows promise for treating cardiovascular disease.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Gene therapy shows promise for treating cardiovascular disease. According to a study from Japan, "recent progress in molecular and cellular biology has developed numerous effective cardiovascular...

HEART software enables beat-to-beat analysis.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The Matlab-based HEART software is a versatile cardiovascular analysis system. Programmers in the United States developed a software suite "for beat-to-beat analysis of cardiovascular parameters...

Utility of coronary magnetic resonance angiography reviewed.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The utility of coronary magnetic resonance angiography (MRA) has been reviewed. Coronary MRA "continues to advance rapidly from both a technical and clinical perspective," radiologists in Texas...

Nonin 8600V Pulse Oximeter is valid for use with laboratory rats.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Study finds that the Nonin Pulse is able to measure oxygen saturations in laboratory rats. "This report validates the use and limitations of the Nonin Pulse Oximeter for measuring heart rate and...

Lamin A/C mutations can cause serious heart problems.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Mutations in the lamin A/C gene cause cardiomyopathy, often with fatal outcomes. "Most cardiologists are quite alarmed when they learn that a patient carries a mutation in the SCN5a gene responsible...

Researchers review myosin crossbridge activation of cardiac thin filaments.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Researchers discuss mechanisms that are involved in myocardial contraction. "At the level of the myofibrillar proteins, activation of myocardial contraction is thought to involve switch-like...

Most cardiac care patients surveyed know about CPR and CPR education.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- A study in Sweden finds that people particularly those with heart conditions - know about and would learn CPR if the course were offered locally with professional instructors. "The recommended...

AI-700 collaboration, license and supply agreement forged with Acusphere.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Nycomed announced that it has entered into a collaboration, license and supply agreement with Acusphere Inc. (NASDAQ: ACUS). The agreement grants Nycomed the rights to develop and market...

Cardiovascular disease in ESRD patients should be monitored.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Patients with end-stage renal disease (ESRD) should be monitored to prevent progression of cardiovascular calcifications. "There is growing recognition that the progression of cardiovascular...

Health studies target cardiovascular disease.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Health officials are evaluating preliminary findings in round one of a major heart study in Mississippi. "We will have discovered some things we didn't know before and will be in a position to help...

High-energy excimer laser coronary catheter shows promise.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- A novel high-energy laser catheter can facilitate the treatment of coronary artery lesions. Researchers in Canada conducted a study "to evaluate safety and effectiveness of the 0.9 mm excimer laser...

Post-PCI vascular complications heighten long-term cardiac risk.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Vascular complications after percutaneous coronary intervention (PCI) increase the long-term risk of adverse cardiac events. Cardiologists in Washington, D.C. performed a study to determine "the...

Serotonin may be important in regulating cardiovascular function.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Recent studies indicate that serotonin is involved in maintaining normal cardiovascular functioning. "Serotonin is an important neurohormonal factor that has been implicated in cardiovascular...

Tirofiban and ICT used to recanalize occluded coronary artery.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- A regimen of tirofiban and alteplase has been successfully used to recanalize an occluded coronary artery. According to a case report from Germany, a "51 year-old male was admitted to our...

Utility of MRI guidance in coronary interventions reviewed.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The utility of MRI guidance in coronary interventions has been reviewed. "Magnetic resonance imaging (MRI) guidance for coronary interventions offers potential advantages over conventional x-ray...

Utility of implantable cardioverter defibrillator reviewed.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The utility of implantable cardioverter defibrillator (ICD) treatment has been reviewed. "Since the first clinical use of implantable defibrillator in human, the technology and the function" of...

Cyclic nucleotides may be novel target for care of cardiovascular diseases.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The transport systems of cyclic nucleotides may be a novel target for preventing or treating various cardiovascular diseases, researchers say. "We examined the effect of diphenylamine-2-carboxylic...

Hemodynamic effects of vessel opening may lead to in-stent restenosis.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The hemodynamic effects of stenosis resolution may underlie stent-related complications. "Implantation of expandable stents into stenotic arteries after percutaneous coronary intervention to relieve...

Memorial Health breaks ground for heart and vascular institute.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Memorial Health officially broke ground for a new $45 million, 189,000-square-foot facility that will house the Heart and Vascular Institute at Memorial Health University Medical Center in southeast...

Safe practices for spinal anesthesia during caesarian section given.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Study describes safe practices for spinal anesthesia during caesarian section, with regard to hemodynamic instability. According to a study from South Africa, "Spinal anesthesia is the method of...

Endothelial progenitor cell mobilization encourages aortic repair.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Endothelial progenitor cell mobilization encourages aortic repair. "Rapid endothelialization of prosthetic vessels is essential to avoid fatal complications. We hypothesized that there may be...

Store-operated calcium ion entry regulates vascular smooth muscle gene activity.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Store-operated calcium ion entry regulates vascular smooth muscle gene activity. "Ca2+-regulated gene transcription is a critical component of arterial responses to injury, hypertension, and...

OTC statin options discussed at inaugural meeting of Midwest Lipid Association.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The National Lipid Association (NLA) announced the inaugural meeting of the Midwest Lipid Association (MWLA). More than 100 lipid specialists primarily from around the Midwestern United States are...

Company reiterates guidance for STRIDE-2 trial enrollment.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Encysive Pharmaceuticals (ENCY) confirmed enrollment in the STRIDE-2 clinical trial is expected to complete in the third quarter of 2004. Enrollment is close to three-quarters complete in this...

Researchers develop milrinone pharmacokinetic model in children.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Study creates a pharmacokinetic model for milrinone in children under 6 years old to avoid low cardiac output syndrome postoperatively. According to published research from the United States, "The...

Beta-blocker drugs well tolerated for heart failure patients.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo, according to new research. ...

Carvedilol prevents cardiac remodeling in coronary artery disease.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Carvedilol prevents progression of ventricular remodeling and improves long-term outcome for patients with ischemic heart failure. According to published research from New Zealand, "Cardiac...

Delisting demanded from Berlin Stock Exchange.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Miravant Medical Technologies (OTCBB:MRVT) announced that it has demanded an immediate delisting from the Berlin Stock Exchange in an attempt to prevent potential manipulative trading practices that are...

Studies show Lovenox as an effective treatment of acute coronary syndromes.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Results of two new randomized clinical studies confirm that Lovenox (enoxaparin sodium injection) is an effective and safe antithrombotic agent in patients with non-ST-segment elevation (NSTE) acute...

Company cleared to market Powerheart G3 public access defibrillator.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Cardiac Science, Inc., (DFIB) announced the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its new Powerheart G3-Automatic automated external defibrillator (AED),...

Diagnostics company granted sublicense for assay to assess cardiovascular risk.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Ortho-Clinical Diagnostics announced that it has been granted a non-exclusive sublicense by Dade Behring for the development, manufacture and marketing of a high sensitivity CRP assay for the assessment...

Implantable defibrillators reduce mortality in a heart failure study.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- A large German study finds that implantable cardiac defibrillators (ICDs) resulted in a significant reduction in mortality. "To date, generally accepted indications for prophylactic defibrillator...

CombiMatrix announces human drug metabolism array.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Acacia Research Corp.'s (CBMX) CombiMatrix group has made available to researchers a new CustomArray Human Drug Metabolism Array. This array enables researchers to screen a panel of genes and...

Support vector machine approach helps identify torsade-causing drugs.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The support vector machine (SVM) statistical learning method may be useful for identifying drugs with torsade-causing potential. "In an effort to facilitate drug discovery, computational methods...

Third phase 3 study initiated for Cardiome's atrial arrhythmia product.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Cardiome Pharma Corp (COM) has initiated its third phase 3 efficacy study of RSD1235 for the acute treatment of atrial fibrillation (AF). The study, called ACT 3 (atrial arrhythmia conversion trial...

AED maker announces preliminary second-quarter revenue results.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Cardiac Science, Inc., (DFIB) announced revenue for its second quarter ended June 30, 2004 was within the range of company guidance and is expected to be between $17.3-17.5 million, representing...

Gene-transfer therapy company announces $9.85 million private placement.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Corautus Genetics, Inc., (CAQ) has raised $9.85 million in a private placement of common stock. The first tranche of the investment in the amount of $4.925 million has closed. The second...

Pharmaceutical company partners to support marathon relay event.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Silicon Laboratories Inc. (SLAB), Junior Achievement (JA), and the RunTex Foundation have formed a partnership to bring a new marathon relay event to Austin, Texas, on July 4, 2005. In conjunction...

U.S. adults take blame for obesity, Britons share with manufacturers.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- A global study shows that U.S. adults are accepting personal responsibility for the obesity epidemic, but the British share blame with food manufacturers. The study was conducted by Universal McCann...

Drug company launches initiative to expand prescription medication access.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Pfizer Inc said it will launch the pharmaceutical industry's most comprehensive initiative to significantly expand access to prescription medicines across the United States. The program will...

Insurer says claims up due to obesity, encourages healthier workplace practices.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Corporate America has a responsibility to the health of its workforce, and the health of its bottom line is to address workforce obesity, according to UnumProvident, the nation's leading provider of...

First patient enrolled in FLAME clinical trial.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that enrollment has begun in its clinical trial known as FLAME. This prospective, multicenter, randomized study will involve approximately 500 patients...

Guidelines urge drastic lowering of bad cholesterol for heart attack patients.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Health officials are issuing a stern message to people who have recently had a heart attack: Lower your "bad cholesterol" to rock-bottom levels. "The concept here is that lower is better with...

Gene therapy alternative to calcium channel blockers works in animals.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- In animal studies, scientists at Johns Hopkins have developed what is believed to be the first successful gene therapy that mimics the action of calcium channel blockers, agents widely used in the...

Carvedilol better than metoprolol tartrate in reducing mortality.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- A recent trial shows that carvedilol is significantly better than metoprolol tartrate in reducing mortality. "beta-Adrenergic blockade is commonly and successfully used to treat chronic heart...

Carvedilol has good tolerability.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Clinical trials show that carvedilol is well tolerated, even in patients with advanced disease. According to recent research from Australia, "An extensive clinical trials database now exists to...

Carvedilol is a powerful treatment for heart failure patients.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Clinical trials prove the efficacy of carvedilol in reducing morbidity, mortality and hospital stays of heart failure patients. "The safety, tolerability and hemodynamic effects of carvedilol in...

Carvedilol is beneficial for patients in severe heart failure.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Large clinical trial found that carvedilol greatly reduces mortality and hospital length of stay for patients with severe heart failure. "The impact of carvedilol on the survival of patients with...

Combining beta-blockers and ACE inhibitors may best reduce heart failure mortality.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Combining beta-blockers and angiotensin-converting enzyme (ACE) inhibitors may produce the best reduction in mortality from heart failure. "Left ventricular (LV) remodeling has an important role in...

First patient enrolled in ORBIT trial with implantation of cardiac device.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Biotronik announced the first implantation of a cardiac resynchronization device for treating heart failure within the ORBIT study, which was performed on June 21, 2004. "The ORBIT study evaluates...

Heart failure will likely increase as the population ages.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Hypertension often leads to increased wall stress, resulting in cardiac hypertrophy, which is a predictor of heart failure. "The heart failure syndrome is one the most common chronic diseases in...

Memorial Hospital of Tennessee granted chest pain center accreditation.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The Society of Chest Pain Centers has granted the designation of Accredited Chest Pain Center to Memorial Hospital, making it the 15th facility in Tennessee, and 51st in the nation to be accredited. ...

Multicenter trial of Aquapheresis therapy initiated.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- CHF Solutions, Inc., announced that enrollment has begun in a large clinical trial to evaluate its unique Aquapheresis therapy compared with traditional diuretic therapy. Administered via CHF...

Predischarge initiation of carvedilol helps postdischarge patient compliance.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Study shows that patients who started carvedilol before hospital discharge were more likely to continue the medication. According to published research from the United States, "The use of...

Trial to evaluate CRT therapy in heart failure patients with mild symptoms.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The number of patients who could benefit from a landmark device-based therapy called cardiac resynchronization therapy (CRT) could dramatically increase if results of a new worldwide clinical trial...

ET-1-mediated coronary vasoconstriction did not limit heart's oxygen uptake.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Peptide endothelin-1 (ET-1)-mediated coronary vasoconstriction did not limit oxygen uptake by the failing heart, researchers report. "Circulating levels of the potent vasoconstrictor ET-1 are...

Heart rate variations during graded LBNP are reproducible.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Researchers find that cardiovascular responses to sub- and maximal lower body negative pressure (LBNP) are reproducible. "The reproducibility of heart rate variability (HRV) measures during graded...

HRT could have more benefits than risks when started early in menopause.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Do not categorically reject hormone replacement therapy (HRT) just yet: When women begin HRT before age 60, their risk of death is 39% less than women not on hormones, according to a new study. The...

Transdermal and low-dose oral ERT does not affect homocysteine metabolism.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- According to a report in the journal Atherosclerosis, transdermal and low-dose oral estrogen replacement therapy does not significantly affect homocysteine metabolism. "This finding does not...

More intensive cholesterol treatment an option for high-risk heart patients.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- More intensive cholesterol treatment is an option for people at high risk for heart attack and death from cardiovascular disease, according to updated recommendations from the National Cholesterol...

Most Americans not sure about the sources of high cholesterol.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Results from a recent nationwide survey showed that most respondents did not know that high cholesterol comes from two sources, even though the respondents reported having high cholesterol. When...

Decision aid may help hypertensive patients choose treatment.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Decision aid helps newly diagnosed hypertensive patients decide about taking medicine. "This study adopted a qualitative approach to explore patient views on the usefulness of a decision analytic...